Human repeat insult patch tests using a rinse-off facial product containing 42.69% dextrin found no skin irritation or sensitization in 54 subjects
This applies broadly to people in their mid-thirties and older, where natural GHK-Cu plasma levels have been declining for years and the skins collagen synthesis capacity is already reduced from peak
The KFF 2025 Employer Health Benefits Survey showed even faster acceleration: 43% of firms with 5,000+ workers now cover GLP-1s for weight loss (up from 28% in 2024), with 30% of firms with 1,0004,999 workers and 16% of firms with 200999 workers following suit ( [6] )
In the study, participants with CKD and Type 2 diabetes taking semaglutide for more than three years had a 24% lower chance of having what researchers called a major kidney disease event, including kidney failure, needing dialysis or a transplant, decline in kidney function, and kidney-related or cardiovascular death